ClinVar Miner

Submissions for variant NM_000543.5(SMPD1):c.688C>T (p.Arg230Cys)

gnomAD frequency: 0.00001  dbSNP: rs989639224
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000409293 SCV000485757 likely pathogenic Niemann-Pick disease, type A 2016-02-09 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001229670 SCV001402124 pathogenic Niemann-Pick disease, type B; Niemann-Pick disease, type A 2023-10-29 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 230 of the SMPD1 protein (p.Arg230Cys). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This missense change has been observed in individual(s) with acid sphingomyelinase (ASM) deficiency (PMID: 17011332, 19405096, 22818240, 27338287). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Arg228Cys. ClinVar contains an entry for this variant (Variation ID: 370432). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SMPD1 function (PMID: 19405096). For these reasons, this variant has been classified as Pathogenic.
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV001248876 SCV001422551 pathogenic Sphingomyelin/cholesterol lipidosis 2020-01-22 criteria provided, single submitter curation The p.Arg230Cys variant in SMPD1 (also known as p.Arg228Cys due to a difference in cDNA numbering) has been reported in at least 7 individuals with Niemann-Pick disease (PMID: 17011332, 22818240, 23356216, 23356216, 23252888, 19405096) and has been identified in 0.001% (1/111638) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs989639224). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (VariationID: 370432) as likely pathogenic by Counsyl. In vitro functional studies provide some evidence that the p.Arg230Cys variant may impact protein function (PMID: 19405096). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in 4 affected homozygotes increases the likelihood that the p.Arg230Cys variant is pathogenic (PMID: 17011332, 22818240, 23356216, 19405096). The phenotype of individuals homozygous and compound heterozygous for this variant is highly specific for Niemann-Pick disease based on acid sphingomyelinase activity being <10% of normal, consistent with disease (PMID: 23252888, 22818240, 19405096, 23356216). In summary, this variant meets criteria to be classified as pathogenic for Niemann-Pick disease in an autosomal recessive manner based on in vitro studies and low prevalence in the general population. ACMG/AMP Criteria applied: PS3, PM2, PM3, PP3, PP4 (Richards 2015).
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics RCV001229670 SCV001622390 pathogenic Niemann-Pick disease, type B; Niemann-Pick disease, type A 2021-01-08 criteria provided, single submitter clinical testing A homozygous missense variant in exon 2 of the SMPD1 gene that results in the amino acid substitution of Cysteine for Arginine at codon 230 was detected. The observed variant c.688C>T (p.Arg230Cys) has not been reported in the 1000 genomes and gnomAD databases. The variant is reported in ClinVar as a pathogenic variant (ID 357985). The in silico prediction of the variant is damaging by MutationTaster2. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as pathogenic.
AiLife Diagnostics, AiLife Diagnostics RCV002223835 SCV002502706 likely pathogenic not provided 2020-06-07 criteria provided, single submitter clinical testing
Baylor Genetics RCV000409293 SCV004203233 pathogenic Niemann-Pick disease, type A 2023-06-15 criteria provided, single submitter clinical testing
Natera, Inc. RCV000409293 SCV002091690 pathogenic Niemann-Pick disease, type A 2017-08-19 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.